Although the current number of new agents in short supply is much lower than at its peak more than 10 years ago, drug shortages are an ongoing problem in the United States with no end in sight.
However, an FDA report acknowledged that this decline is a step in the right direction, but these shortages “continue to pose a real challenge to public health.” Although there were only 48 “new” drug shortages, there are more than 100 active shortages on the FDA